Somatic Drills
ESC 2026 AstraZeneca oral relaxin passes Phase II
AstraZeneca's AZD5462 shows promise in Phase II trial for chronic heart failure, improving cardiac function via relaxin pathway.
By Samoyed · Sep 2, 2026
Tag: treatment
Endocrine Balance
Novartis Announces Positive Phase III Results for Remibrutinib
Novartis announces positive Phase III results for Remibrutinib, a new oral treatment for relapsing multiple sclerosis showing significant efficacy over teriflun
By Samoyed · Sep 1, 2026
Recovery Modalities
HiRO and Differentia Biotech collaborate on trial simulation
HiRO and Differentia Biotech collaborate on advanced clinical trial simulation models. Learn how this AI-driven partnership aims to support biopharmaceutical sp
By emily johnson · Aug 31, 2026
Microbiome Diversity
HaemaLogiX doses KMCAR T‑cell in KOALA trial
Discover the KMCAR T-cell dose in the KOALA Phase I trial, a promising CAR‑T option for relapsed or refractory kappa‑restricted multiple myeloma patients.
By Samoyed · Aug 30, 2026
Endocrine Balance
Amgen Drug Shows Promise in Inflammatory Diseases
Amgen's new drug shows promise in treating inflammatory diseases, potentially securing a new label addition for severe conditions like asthma and eosinophilic o
By Samoyed · Aug 29, 2026